NFKB1 and neoplasm: TGFβ-induced EMT mediated by inflammatory cells in the tumor microenvironment is promoted by the leukotriene B4 receptor 2, which, in response to leukotriene B4, activates reactive oxygen species (ROS) and NF-κB transcriptional activity that facilitate the establishment of EMT by TGFβ [71].